Top Markets
#1 Nesa Nesa +721.69%
#2 Merlin's Seal BTC Merlin's Seal BTC +45.58%
#3 EXOD EXOD +22.78%
#4 Pons Pons +16.93%
#5 Prom Prom +12.59%
#6 Venom Venom +10.85%
#7 MetaDAO MetaDAO +9.76%
#8 PondCoin PondCoin +8.89%
#9 Cash Cat Cash Cat +8.58%
#10 Fartcoin Fartcoin +8.35%
Coin of the day
Nesa Nesa
設定
言語
日本
通貨
USD
テーマ
Photocure ASA Photocure ASA

Photocure ASA

PHO
株式のランク #19788
Photocure ASA is a specialized pharmaceutical enterprise focused on the... Photocure ASA is a specialized pharmaceutical enterprise focused on the development, manufacturing, commercialization, and distribution of medicinal products. Its operational footprint extends across multiple European nations, including the Nordic region, Germany, France, Austria, the United Kingdom, the Netherlands, and Italy, in addition to the United States. The company's primary offering, Hexvix/Cysview, aids in the identification and ongoing management of bladder cancer. Moreover, Photocure is actively progressing Cevira, a therapeutic agent in development targeting human papilloma virus (HPV) infections and pre-cancerous lesions of the cervix. The firm distributes its products to pharmaceutical wholesalers, pharmacies, and healthcare institutions through collaborative licensing arrangements. Founded in 1993, Photocure ASA maintains its corporate headquarters in Oslo, Norway.
株価
$5.66
最終同期: 2026-08-25
時価総額
$150.59M
変化（1日）
0.00%
変化（1年）
-7.22%
国
NO
取引 Photocure ASA (PHO)

カテゴリー

Healthcare
Photocure ASA（PHO）のEPS
2026 時点のEPS TTM: 0
Photocure ASAの最新の財務報告と株価によると、同社の現在のEPS（TTM）は0です。2026年末には、EPSは0で、2026年のEPS0と同等でした。
Photocure ASAのEPS履歴（2026から2026まで）
各年末時点のEPS
年 EPS 変化
提供された日付のデータは十分ではありません。
同様の企業または競合他社のEPS
企業 EPS EPSの差 国
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $17.32 -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $27.74 -
NL
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 $-7.98 -
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $-5.29 -
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH